The past year has been a good year for neurology. With the major progress for neurological treatments and the aging of the population, neurology is becoming one of the key disciplines of medicine. Its organized bodies like the World Federation of Neurology, the regional societies in America, Asia and Europe as well as the specialty societies for stroke, movement disorders, dementia, multiple sclerosis and many other diseases are becoming the key drivers of this development.
Tag
treatment
-
-
As in the previous year, Neuropenews asked EAN committee members, panel chairs, speakers etc. which session one should not miss at the upcoming congress in Copenhagen 2016. Please find their answers below!
-
Forum
EAN Guideline: Concomitant use of Cholinesterase Inhibitors and Memantine in Alzheimer’s Disease
May 1, 2015In the June issue of the European Journal of Neurology, members of the Subspecialty Scientific Panel Dementia and Cognitive Disorders panel of the European Academy of Neurology publish a Guideline on concomitant use of cholinesterase inhibitors (ChEI) and memantine in moderate to severe Alzheimer’s disease (AD). -
The Editors have – together with the Scientific Committee – decided that new EFNS guideline papers will be presented in the Forum of NEUROPENEWS. In the May issue of the European Journal of Neurology the new EFNS/ENS Guidelines for the… Continue Reading
-
When I had just been appointed a consultant in 1975, a renal physician friend examined the contents of my smart new diagnostic bag: "ophthalmoscope, red pin, tuning forks, cotton wool, pins, orange sticks, tendon hammer, lots of things to find out what's wrong with people and nothing to get them better with!" Everyone laughed.